Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
34%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
CANC
51
HOLDINGS
27%
ALSO IN HRTS
HRTS
44
HOLDINGS
32%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in HRTS
Overlap
ELI LILLY & CO 5.1% 8.6% 5.1%
ROCHE HOLDINGS LTD-SPONS ADR 4.5% 4.3% 4.3%
ASTRAZENECA PLC 4.1% 4.3% 4.1%
NOVARTIS AG 4.2% 3.2% 3.2%
ABBVIE INC 2.5% 3.3% 2.5%
CANC Overweight Relative to HRTS
REVOLUTION MEDICINES, INC. 5.6%
GENMAB A/S SPONSORED ADR 5.2%
ARCELLX, INC. 3.8%
NUVALENT, INC. CLASS A 3.6%
EXELIXIS INC 2.8%
MERUS N.V. 2.7%
IDEAYA BIOSCIENCES, INC. 2.6%
BEIGENE LTD. SPONSORED ADR 2.6%
IMMUNOME, INC. 2.4%
ZAI LAB LTD. UNSPONSORED ADR 2.1%
CANC Underweight Relative to HRTS
UNITEDHEALTH GROUP INC -4.9%
ABBOTT LABORATORIES -4.2%
THERMO FISHER SCIENTIFIC INC -3.6%
BOSTON SCIENTIFIC CORP -3.6%
ELI LILLY & CO -3.5%
MEDTRONIC PLC -3.1%
NOVO NORDISK A/S-B -2.6%
VERTEX PHARMACEUTICALS INC -2.5%
CYTOKINETICS INC -2.4%
DANAHER CORP -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY